EverQuote saw its IBD SmartSelect Composite Rating rise to 96 Tuesday, up from 91 the day before.
Looking For Winning Stocks? How To Invest In Both Bull And Bear Markets
The new rating shows the stock is outpacing 96% of all stocks when it comes to the most important stock-picking criteria. The best stocks tend to have a 95 or better grade as they start a significant move so be sure to keep that in mind when looking for the best stocks to buy and watch.
EverQuote is not currently near a proper buy point. Look for the stock to form and break out of a new chart pattern.
The stock earns an 81 EPS Rating, which means its recent quarterly and annual earnings growth tops 81% of all stocks.
Its Accumulation/Distribution Rating of C shows a roughly equal amount of buying and selling by institutional investors over the last 13 weeks.
In Q1, the company reported 320% EPS growth. Revenue growth came in at 83%, down from 165% in the prior quarter.
EverQuote holds the No. 3 rank among its peers in the Insurance-Diversified industry group. Palomar Holdings is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
